Japan Tissue Engineering Co., Ltd.

As of March 31, 2025, Japan Tissue Engineering Co., Ltd. carries a market capitalization of 18.56B, placing it among publicly traded companies globally. Its enterprise value stands at 14.67B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Japan Tissue Engineering Co., Ltd.'s next confirmed earnings release is scheduled for October 30, 2026.

As of March 31, 2025, Japan Tissue Engineering Co., Ltd. has 40.61M shares outstanding.

These figures are as of March 31, 2025.

As of March 31, 2025, Japan Tissue Engineering Co., Ltd. maintains a current ratio of 7.57, meaning it holds 7.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2025.

Over the twelve months ended March 31, 2025, Japan Tissue Engineering Co., Ltd. recorded 988,000.00 in income tax expense.

As of the close on October 22, 2026, Japan Tissue Engineering Co., Ltd.'s stock has gained approximately 44.60% over the past 52 weeks. The 50-day moving average sits at 831.64, while the 200-day moving average is 667.89.

These figures are as of March 31, 2025. Total book value stands at 5.83B, with working capital of 4.19B providing operational flexibility.

Japan Tissue Engineering Co., Ltd.'s most recent stock split took place on March 27, 2014 with a 1:200 split ratio.